Recommendations for Regulating Intoxicating Cannabinoids Chemically Synthesized from Hemp Summary
“The U.S. 2018 Farm Bill may have inadvertently legalized the chemical conversion of hemp-derived cannabidiol (CBD) and other phytocannabinoids (those derived directly from the plant) into intoxicating minor cannabinoids like delta-8 tetrahydrocannabinol (∆8-THC), leading to a booming industry without adequate regulatory oversight. Our stance at D4DPR is that all intoxicating cannabinoids should be subject to a regulatory framework to ensure public safety.”
D4DPR Recommended Policy
● Implement a regulatory framework for all intoxicating cannabinoids, regardless of their source (hemp, cannabis, laboratory synthesis, or via bioreactors/fermentation). This framework should include:
- Licensing requirements for dispensaries selling intoxicating cannabinoids.
- Appropriate taxation to fund regulatory oversight and public health initiatives.
- Prohibition of sale to minors and packaging that does not appeal to children.
- Childproof containers and clear labeling of intoxicating effects with the International Intoxication Cannabinoid Product Symbol (ASTM D8441).
- Mandatory laboratory testing with required Certificate of Analysis (CoA) to assure purity and potency.
- As many of these minor cannabinoids are newly described and difficult to detect, research into toxicology, clinical safety, and laboratory testing standards must be conducted.
Read their entire position paper here and click here to learn more about Doctors for Drug Policy Reform. D4DPR’s efforts were recently highlighted by Marijuana Moment.